Jounce Therapeutics Inc Asset Turnover Ratio (JNCE), as of fourth quarter 2022, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Jounce Therapeutics inc   (NASDAQ: JNCE)
 

Jounce Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Jounce Therapeutics Inc asset turnover ratio, the ability of Jounce Therapeutics Inc 's assets to generate revenue in the fourth quarter 2022, increased sequentially to 0.44 in the fourth quarter (Dec 31 2022), JNCE's balance sheet remain strong.

Within sector Jounce Therapeutics inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the fourth quarter 2022 compared to previous quarter at no. .

Asset Turnover Ratio Definition



JNCE Asset Turnover Ratio (Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
Y / Y Asset Change -15.78 % -43.68 % -38.79 % -29.83 % 5.15 %
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) 0.44 - - - -
JNCE's Total Ranking # # # # #
Seq. Asset Change 35.21 % -15.53 % -12.58 % -15.66 % -9.58 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 







Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2022, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2022 Assets at quarter ending Dec 31 2022
Etao International Co Ltd   1.10 $ 58.060  Millions$ 52.990  Millions
Medpace Holdings Inc   1.09 $ 1,459.996  Millions$ 1,335.180  Millions
Nrc Health  1.09 $ 151.568  Millions$ 138.708  Millions
Skinvisible Inc   1.08 $ 0.279  Millions$ 0.258  Millions
Warby Parker Inc   1.08 $ 598.112  Millions$ 551.771  Millions
Electromed Inc   1.08 $ 43.797  Millions$ 40.470  Millions
Yunhong Green Cti Ltd   1.08 $ 18.048  Millions$ 16.747  Millions
Oak Street Health Inc   1.06 $ 2,160.900  Millions$ 2,030.400  Millions
Biolase Inc   1.06 $ 48.462  Millions$ 45.537  Millions
Cv Sciences Inc   1.05 $ 16.205  Millions$ 15.485  Millions
Xtant Medical Holdings Inc   1.04 $ 57.969  Millions$ 55.540  Millions
Phibro Animal Health Corporation  1.04 $ 972.051  Millions$ 931.989  Millions
Shockwave Medical Inc   1.02 $ 489.733  Millions$ 477.891  Millions
Tactile Systems Technology Inc   1.01 $ 246.785  Millions$ 243.459  Millions
Orthofix Medical Inc   1.01 $ 460.713  Millions$ 457.984  Millions
Universal Health Services Inc   1.01 $ 13,399.370  Millions$ 13,328.409  Millions
Organogenesis Holdings Inc   1.00 $ 450.893  Millions$ 449.815  Millions
Lifeloc Technologies Inc   1.00 $ 8.482  Millions$ 8.463  Millions
Addus Homecare Corp  0.99 $ 951.120  Millions$ 958.917  Millions
Fuse Medical Inc   0.98 $ 18.645  Millions$ 18.943  Millions
Inspire Medical Systems inc   0.97 $ 407.856  Millions$ 418.530  Millions
Paratek Pharmaceuticals Inc   0.97 $ 160.268  Millions$ 165.928  Millions
Semler Scientific inc   0.96 $ 56.686  Millions$ 59.171  Millions
Pro dex Inc   0.95 $ 44.249  Millions$ 46.689  Millions
Zymeworks Inc   0.94 $ 412.482  Millions$ 436.983  Millions
Ensign Group Inc  0.94 $ 3,025.468  Millions$ 3,221.632  Millions
Electromedical Technologies Inc   0.94 $ 1.150  Millions$ 1.226  Millions
Irhythm Holdings Inc   0.94 $ 410.921  Millions$ 438.254  Millions
The Pennant Group Inc   0.94 $ 473.241  Millions$ 505.217  Millions
Alpha Pro Tech Ltd   0.93 $ 61.981  Millions$ 66.765  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.